Oral bisphosphonates and oesophageal cancer.
Wysowski
Diane K
DK
D000284:Administration, Oral; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D004938:Esophageal Neoplasms / Q000139:chemically induced*; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*
D050071:Bone Density Conservation Agents; D004164:Diphosphonates